调节的细胞死亡方式:破解耐受性的temozolomide质母细胞瘤治疗

Tatiana A Mishchenko1, Oluwabukolami J Olajide1, Ekaterina N Gorshkova1

  • 1Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.

Trends in cancer
|February 11, 2025
PubMed
概括

泰莫佐洛米德化疗可以触发质母细胞瘤中的各种细胞死亡类型. 利用这些细胞死亡可以克服治疗耐药性并改善质母细胞瘤治疗结果.

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K